#Ucugen breaking out of the ascending triangle. - Trend continuation to 20.00 USD expected! - Ocugen Inc. is a biopharmaceutical company focused on the development, development and commercialization therapies for eye diseases. - Ocugen is developing a vaccine against COVID-19. - Number of employees: 15 people.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.